New research partnership promises enhanced precision in diagnosing and targeting HER2-expressing breast cancers....
Rapidly growing lung health company aims to redefine early diagnosis and precision lung cancer care using multi-modal artificial intelligence (AI)....
New Solution Enhances Infection Prevention During Peripheral Nerve Block Applications...
New collaboration enhances access and benefits the community by bringing best-in-class spine and complex musculoskeletal care to North County....
Unveiled at ESCMID Global Congress 2025, the new Hyperbaric Heating-based platform eliminates the need for extraction kits—delivering faster, simpler, and cost-effective molecular workflows across diverse research and diagnostic applications....
Utilizing advanced TMS technology, EXOMIND™ offers a drug-free, precision-based solution for mood regulation and cognitive enhancement in clinical and wellness settings....
New collaboration removes adoption barriers by offering streamlined evaluation of MoxiePlex systems through a CLIA-accredited lab, combining imaging expertise with validated spatial biology support. ...
Hours, Not Days: EU Approval Accelerates 5-Hour Pathogen ID for Critical Cases. Molecular Fingerprinting: AI-Powered ‘DNA Barcode’ Spots 200+ Species, Including Uncultivable Pathogens. Hospital Laboratories Across Europe Now Have Immediate Access To a Fully Certified, Untargeted Molecular Diagnostics Platform. ...
New Category III Codes Facilitate Integration of CaRi-Heart® into Clinical Practice for Enhanced Cardiac Risk Assessment...
Collaboration Enhances Cancer Diagnostics by Integrating Advanced AI into Unified Imaging Workflows...
![[L-R]: Ms. Vivien Tan, XP Business Manager, Siemens Healthineers ASEAN; Prof. Dr. dr. Lina Choridah, Sp.Rad (K), Chairwoman Indonesian Woman Imaging Society; Hendya Perbangkara, Head of Diagnostic Imaging, Siemens Healthineers Indonesia](/uploads/articles/l_r__ms_vivien_tan_xp_business_manager_siemens_healthineers_asean-24188.jpg)
